Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
<h4>Background and purpose</h4> Renal excretion of direct oral anticoagulants (DOACs) varies depending on the drug. Hypothetically, an increased glomerular filtration rate (GFR) may lead to suboptimal dosing and a higher thromboembolic events incidence. However, real-world patient data d...
Main Authors: | Mariana Corrochano, René Acosta-Isaac, Melania Plaza, Rodrigo Muñoz, Sergi Mojal, Carla Moret, Joan Carles Souto |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733869/?tool=EBI |
Similar Items
-
Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants.
by: Mariana Corrochano, et al.
Published: (2022-01-01) -
Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data.
by: Carla Moret, et al.
Published: (2023-01-01) -
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
by: Marina Canyelles, et al.
Published: (2022-03-01) -
Ischaemic stroke in patients treated with oral anticoagulants
by: L.M. Cano, et al.
Published: (2016-07-01) -
Oral anticoagulation in chronic kidney disease with atrial fibrillation
by: Pablo Gomez -Fernández, et al.
Published: (2021-03-01)